Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug r (Q31051809)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug r
scientific article

    Statements

    Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug r (English)
    Charles B Hicks
    David A Cooper
    Sharon L Walmsley
    Margaret A Johnson
    Dietmar Neubacher
    Douglas Mayers
    Hernan Valdez
    RESIST investigator group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit